PTK-MS-01

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePTK-MS-01

Drug Alias Nameoral multiple sclerosis therapy (Paratek Pharmaceuticals)oral multiple sclerosis therapy (Paratek/Merck Serono)tetracyclines (Paratek)Tetracycline Derivatives (Paratek)PTK-MS-01

ClassificationSmall molecules

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesParatek Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Serono Sa Paratek Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A